Association of APOL1 Risk Alleles with Cardiovascular Disease in African Americans in the Million Veteran Program
| Autor: | Bick, Alexander G, Akwo, Elvis, Robinson-Cohen, Cassianne, Lee, Kyung, Lynch, Julie, Assimes, Themistocles L, DuVall, Scott, Edwards, Todd, Fang, Huaying, Freiberg, S. Matthew, Giri, Ayush, Huffman, Jennifer E, Huang, Jie, Hull, Leland, Kember, Rachel L, Klarin, Derek, Lee, Jennifer S, Levin, Michael, Miller, Donald R, Natarajan, Pradeep, Saleheen, Danish, Shao, Qing, Sun, Yan V, Tang, Hua, Wilson, Otis, Chang, Kyong-Mi, Cho, Kelly, Concato, John, Gaziano, J. Michael, Kathiresan, Sekar, O’Donnell, Christopher J, Rader, Daniel J, Tsao, Philip S, Wilson, Peter W, Hung, Adriana M, Damrauer, Scott M |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male Risk Polymorphism Genetic Genotype Incidence Myocardial Infarction Coronary Artery Disease Middle Aged Apolipoprotein L1 Article United States Black or African American Peripheral Arterial Disease Electronic Health Records Humans Female Genetic Predisposition to Disease Alleles Retrospective Studies Veterans |
| Zdroj: | Circulation |
| Popis: | BACKGROUND: Approximately 13% of African-American individuals carry two copies of the APOL1 risk alleles G1 or G2, which are associated with 1.5-2.5 fold increased risk of chronic kidney disease (CKD). There have been conflicting reports as to whether an association exists between APOL1 risk alleles and cardiovascular disease, independent of the effects of APOL1 on kidney disease. We sought to test the association of APOL1 G1/G2 alleles with coronary artery disease (CAD), peripheral artery disease (PAD), and stroke among African American individuals in the Million Veteran Program (MVP). METHODS: We performed a time-to-event analysis of retrospective electronic health record (EHR) data using Cox proportional hazard and competing risks Fine and Gray sub-distribution hazard models. The primary exposure was APOL1 risk allele status. The primary outcome was incident CAD amongst individuals without CKD during the 12.5 year follow up period. Separately we analyzed the cross-sectional association of APOL1 risk allele status with lipid traits and 115 cardiovascular diseases using phenome-wide association. RESULTS: Among 30,903 African American MVP participants, 3,941 (13%) carried the two APOL1 risk allele high-risk genotype. Individuals with normal kidney function at baseline with two risk alleles had slightly higher risk of developing CAD compared to those with no risk alleles (Hazard Ratio (HR): 1.11, 95% Confidence Interval (CI): 1.01-1.21, p=0.039). Similarly, modest associations were identified with incident stroke (HR: 1.20, 95% CI: 1.05-1.36, p=0.007) and PAD (HR: 1.15, 95% CI:1.01-1.29, p=0.031). When modeling both cardiovascular and renal outcomes, APOL1 was strongly associated with incident renal disease, while no significant association with the cardiovascular disease endpoints could be detected. Cardiovascular phenome-wide association analyses did not identify additional significant associations with cardiovascular disease subsets. CONCLUSIONS: APOL1 risk variants display a modest association with cardiovascular disease and this association is likely mediated by the known APOL1 association with CKD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|